

Saccharomyces cerevisiae is a harmless yeast found in food, the body, and the environment. In certain individuals, the immune system reacts to this yeast and produces antibodies against it. These antibodies, called anti-Saccharomyces cerevisiae antibodies (ASCA), are commonly linked with Crohn’s disease. Specifically, the ASCA-IgA test looks for IgA antibodies, which are closely associated with mucosal immunity in the intestines.
Detecting ASCA-IgA helps doctors differentiate Crohn’s disease from ulcerative colitis, two major forms of IBD that affect different regions of the gastrointestinal tract and often need different treatment approaches. The test is recommended for patients with gastrointestinal symptoms such as long-standing diarrhea, abdominal pain, unexplained weight loss, or rectal bleeding, especially if the diagnosis is unclear.
No special preparation is needed for getting the ASCA - IgA antibody test done. However, be sure to inform the doctor about any medications or supplements being taken, as they may affect the test results.
Lab test results may vary across different laboratories. Abnormal test results require expert interpretation. Therefore, never try to self-medicate based solely on these results. Always consult a doctor for a proper understanding of the test results.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The ASCA - IgA antibody test measures IgA antibodies in the blood and is used in gastroenterology to help differentiate between inflammatory bowel diseases, specifically Crohn’s disease and ulcerative colitis. IgA antibodies are primarily associated with mucosal immunity in the intestines.
Elevated ASCA-IgA levels are often linked with Crohn’s disease, providing valuable information when symptoms overlap or are unclear. Detecting ASCA-IgA helps doctors make a more precise diagnosis and guide treatment strategies tailored to the specific type of IBD.
A positive result supports the likelihood of Crohn’s disease, though it is not definitive on its own. The test is most useful when interpreted alongside clinical symptoms, imaging, colonoscopy, and other laboratory results, helping distinguish Crohn’s disease from ulcerative colitis for accurate management.
The ASCA - IgA antibody test is done:
- To help distinguish between Crohn’s disease and ulcerative colitis
- To provide supportive evidence when IBD symptoms are unclear or overlapping
- To guide doctors in tailoring treatment based on the type of IBD
- To assist in diagnosing Crohn’s disease before initiating targeted therapy
- No special preparation is required.

































